Home > News > Nanobac Pharmaceuticals Inc. Announces Agreement
August 24th, 2006
Nanobac Pharmaceuticals Inc. Announces Agreement
Abstract:
Nanobac Pharmaceuticals, Inc. (OTCBB: NNBP) today announced that it has entered into an agreement and
started work on an animal model to validate a proof of concept that calcifying nanoparticles (CNPs), also known as nanobacteria, promote gallstones. If the proof is validated, it will solve the ages-old mystery of what provokes black pigment gallstones affecting millions of persons, and forge a path to effective early diagnosis and therapy where none are presently available. Results are expected by year-end 2006. Because these gallstones contain material similar to that in kidney stones and breast cancer calcifications, the results could apply to other unsolved calcification-related conditions as well. (PDF)
Source:
Nanobac Pharmaceuticals
Bookmark:
| Related News Press |
Possible Futures
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
Nanomedicine
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
SMART researchers pioneer first-of-its-kind nanosensor for real-time iron detection in plants February 28th, 2025
Announcements
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||